30ml
Dextrose infusions are intravenous solutions containing dextrose (glucose) dissolved in sterile water, primarily used for patients who require parenteral nutrition, hydration, or correction of hypoglycemia. These infusions provide both hydration and caloric intake, making them essential in medical settings where oral or enteral feeding is insufficient or impossible. Dextrose, being a simple sugar, is quickly metabolized by the body, providing an immediate source of energy.
Dosage Forms, Packaging, and Market Information About Dextrose Infusions
Dextrose infusions are available in various concentrations, commonly 5%, 10%, and 50%. These concentrations cater to different clinical needs and are packaged in different forms such as bottles, flexible bags, and plastic containers. Below is a detailed comparison of the top 10 brands available in the market:
| Brand Name |
Concentration |
Packaging Type |
MRP (INR) |
Selling Price (INR) |
MOQ |
Margin for Distributorship (%) |
Margin for Manufacturer (%) |
| Abbott Dextrose |
5% |
500 ml bag |
100 |
70 |
1000 |
30% |
20% |
| Baxter Glucose |
10% |
500 ml bottle |
120 |
80 |
800 |
33% |
22% |
| Fresenius Kabi Dextrose |
5% |
1000 ml bag |
180 |
120 |
500 |
33% |
25% |
| Aculife Dextrose |
10% |
250 ml bag |
70 |
50 |
1500 |
28% |
18% |
| Braun Dextrose |
50% |
50 ml vial |
50 |
30 |
2000 |
40% |
30% |
| Nirlife Dextrose |
5% |
1000 ml bottle |
150 |
100 |
600 |
33% |
22% |
| Hetero Dextrose |
10% |
500 ml bag |
130 |
90 |
700 |
30% |
20% |
| Claris Otsuka Dextrose |
5% |
500 ml bag |
110 |
75 |
900 |
32% |
22% |
| Troikaa Dextrose |
10% |
250 ml bottle |
60 |
40 |
1300 |
33% |
25% |
| Cipla Dextrose |
50% |
100 ml vial |
80 |
55 |
1000 |
31% |
21% |
Market Demand and Growth Statistics
The demand for dextrose infusions has seen a steady increase due to the rising prevalence of medical conditions requiring intravenous hydration and nutritional support. The market has demonstrated consistent growth from 2020 to 2024, driven by increasing healthcare needs and advancements in medical treatments.
Market Growth Statistics (2020-2024):
| Year |
Market Size (INR Crores) |
| 2020 |
450 |
| 2021 |
520 |
| 2022 |
600 |
| 2023 |
680 |
| 2024 |
750 |
Usage Instructions for Effective Results
- Administration: Dextrose infusions should be administered intravenously by healthcare professionals. The rate and volume of infusion depend on the patient’s clinical condition, age, weight, and fluid requirements.
- Dosage: The dosage is patient-specific. For general hydration, a 5% dextrose in water (D5W) is commonly used. Higher concentrations such as 10% or 50% may be used in specific clinical scenarios like severe hypoglycemia.
- Monitoring: Regular monitoring of blood glucose levels and electrolyte balance is crucial during dextrose infusion therapy to prevent adverse effects.
Precautionary Measures to Avoid Side Effects
- Monitor Blood Sugar: Continuous monitoring of blood glucose levels is essential to prevent hyperglycemia or hypoglycemia.
- Allergy Check: Ensure patients do not have allergies to dextrose or any component of the infusion solution.
- Electrolyte Management: Regular monitoring and adjustment of electrolytes are necessary to prevent imbalances, particularly potassium and sodium.
- Infection Control: Use aseptic techniques during the preparation and administration of infusions to prevent infections at the infusion site.
- Controlled Infusion Rate: Infuse the solution gradually, especially in patients with compromised cardiac or renal function, to avoid fluid overload.
Third-Party Manufacturing & PCD Franchise Opportunities
We offer comprehensive opportunities for third-party manufacturing and PCD (Propaganda Cum Distribution) franchises for dextrose infusions. By partnering with us, you can leverage our advanced manufacturing facilities, stringent quality control measures, and extensive market reach to build a successful business in the healthcare sector.
Our third-party manufacturing services ensure high-quality production standards, compliance with regulatory requirements, and reliable supply chains. For PCD franchise partners, we provide robust marketing support, attractive profit margins, and extensive training programs to ensure your business growth and success.
FAQs About Dextrose Infusions
Question 1. What are the primary uses of Dextrose Infusions?
Answer 1. Dextrose infusions are used for providing hydration, nutritional support, and correcting hypoglycemia in patients who cannot receive adequate nutrition orally.
Question 2. What is the typical shelf life of Dextrose Infusions?
Answer 2. The shelf life of dextrose infusions generally ranges from 18 to 24 months, depending on the packaging and storage conditions.
Question 3. What are the common side effects of Dextrose Infusions?
Answer 3. Side effects may include hyperglycemia, electrolyte imbalances, local reactions at the infusion site, and potential allergic reactions.
Question 4. How can I start a PCD franchise for Dextrose Infusions?
Answer 4. To start a PCD franchise, contact us to discuss franchise terms, initial investment, and the support we provide to our partners, including marketing and training.
Question 5. What should be considered in third-party manufacturing of Dextrose Infusions?
Answer 5. Key considerations include adherence to quality control standards, regulatory compliance, and effective supply chain management to ensure timely and consistent product availability.
